NEW YORK, March 10 (GenomeWeb News) - Gen-Probe announced yesterday that it has non-exclusively licensed its hybridization protection assay technology to Alnylam Pharmaceuticals for the development of therapeutic RNA-interfering molecules.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Newsweek discusses the privacy issues raised by digital medicine.
A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.
In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.
Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.